30.03.2011
- Certificates related to Sanofi-Aventis's $20.1 billion acquisition of U.S. biotech firm Genzyme could begin trading on Nasdaq as soon as April 4, depending on the outcome of its...
24.03.2011
- French drugmaker Sanofi-Aventis plans to expand its Merial animal health business through bolt-on acquisitions, its chief executive said on the sidelines of a conference on...
22.03.2011
- Merck & Co and Sanofi-Aventis have terminated their agreement to form a new animal health joint venture. Regarding the reason for the termination, the companies cited the...
18.03.2011
- U.S. biotech company Genzyme said on Thursday it planned joint research projects with Russian high-tech centre ChemRar, joining a growing number of global drugmakers seeking to...